APA (7th ed.) Citation

N, K., VJ, G., CK, T., JS, H., LLY, T., CP, L., & D, S. (2021). Angiotensin receptor-neprilysin inhibitor improves New York Heart Association class and N-terminal-pro B-type natriuretic peptide levels: Initial experience in a Singapore single-centre cohort. Singapore medical journal, 62(7), 359. https://doi.org/10.11622/smedj.2021092

Chicago Style (17th ed.) Citation

N, Koh, Goh VJ, Teoh CK, Hon JS, Teo LLY, Lim CP, and Sim D. "Angiotensin Receptor-neprilysin Inhibitor Improves New York Heart Association Class and N-terminal-pro B-type Natriuretic Peptide Levels: Initial Experience in a Singapore Single-centre Cohort." Singapore Medical Journal 62, no. 7 (2021): 359. https://doi.org/10.11622/smedj.2021092.

MLA (9th ed.) Citation

N, Koh, et al. "Angiotensin Receptor-neprilysin Inhibitor Improves New York Heart Association Class and N-terminal-pro B-type Natriuretic Peptide Levels: Initial Experience in a Singapore Single-centre Cohort." Singapore Medical Journal, vol. 62, no. 7, 2021, p. 359, https://doi.org/10.11622/smedj.2021092.